Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Intra-subject Dose Escalation Phase 1 Study to Determine the Safety and Tolerability of SHJ002 Sterile Ophthalmic Solution in Pediatric Subjects

NCT04928144 is registered in ClinicalTrials.gov with Sunhawk Vision Biotech, Inc. as lead sponsor.

NCT NCT04928144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04928144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Intra-subject Dose Escalation Phase 1 Study to Determine the Safety and Tolerability of SHJ002 Sterile Ophthalmic Solution in Pediatric Subjects
Lead sponsor
Sunhawk Vision Biotech, Inc.
Phase
Phase 1
Overall status
Completed
Start date
July 2, 2021
Completion date
September 17, 2021
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopia